This particular transgenic mouse model was chosen because the degree of allelic exclusion is more potent in this model compared to most other models, obviating the need for including additional targeted genes (e.g., Rag1) that would cripple the immune system.
CXL017 was 20-fold more potent than the model compound against JURKAT cells.
A review of the literature will reveal that much of the past vaccine development work has focused on generating new delivery vehicles and formulations to make a few well-studied antigens more potent in murine models of cancer and clinical trials.
In our study, the supernatant from hUC-MSCs infected with Ad- HGF was more potent in inducing PD model cell regeneration than the supernatant from hUC-MSCs noninfected cells.
For example, most CD4 mAbs studied in RA trials were profoundly depleting, whereas non-depleting mAbs were more potent tolerogens in animal models.
A series of PI3K-beta selective inhibitors, imidazo[1,2-a]-pyrimidin-5(1H -ones, has been rationally designed based on the docking model of the more potent R enantiomer of TGX-221H -onesified by a chasal separation, in a PI3K-been homology model.
Thus, risk models are more potent than dichotomous measures such as IFG and metabolic syndrome and, hence, "contain more information about the future".
There is renewed interest in AMT, however, because while it shares similar pharmacological actions to MTX, the predecessor appears to be more potent when compared in murine models of air-pouch inflammation (~40-fold) and arthritis (~20-fold) [ 15, 16].
10-Deaza-AMT was more potent than MTX toward preclinical models and its 10-ethyl derivative (edatrexate) was even more potent., A 3rd generation analog, 10-propargyl-10-deaza-AMT (PDX), was a less potent DHFR inhibitor than AMT, MTX, or edatrexate but was more active for RFC transport and polyglutamylation than these analogs.
We are using these results and our model to design more potent inhibitors of KMO.
